Cargando…
Mechanistic and Single-Dose In Vivo Therapeutic Studies of Cry5B Anthelmintic Action against Hookworms
BACKGROUND: Hookworm infections are one of the most important parasitic infections of humans worldwide, considered by some second only to malaria in associated disease burden. Single-dose mass drug administration for soil-transmitted helminths, including hookworms, relies primarily on albendazole, w...
Autores principales: | Hu, Yan, Zhan, Bin, Keegan, Brian, Yiu, Ying Y., Miller, Melanie M., Jones, Kathryn, Aroian, Raffi V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493396/ https://www.ncbi.nlm.nih.gov/pubmed/23145203 http://dx.doi.org/10.1371/journal.pntd.0001900 |
Ejemplares similares
-
Bacillus thuringiensis-derived Cry5B Has Potent Anthelmintic Activity against Ascaris suum
por: Urban, Joseph F., et al.
Publicado: (2013) -
In vivo and in vitro studies of Cry5B and nicotinic acetylcholine receptor agonist anthelmintics reveal a powerful and unique combination therapy against intestinal nematode parasites
por: Hu, Yan, et al.
Publicado: (2018) -
Bacillus thuringiensis Cry5B protein as a new pan-hookworm cure
por: Hu, Yan, et al.
Publicado: (2018) -
An Extensive Comparison of the Effect of Anthelmintic Classes on Diverse Nematodes
por: Hu, Yan, et al.
Publicado: (2013) -
Anthelmintics V: Drugs, resistance, and vaccines
por: Aroian, Raffi V., et al.
Publicado: (2023)